MedTrace Logo

Evaluation of Safety, Growth, Tolerance and Effects on the Intestinal Fora of a New Milk for Healthy Infants

NCT00920166 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 97

Last updated 2009-06-15

No results posted yet for this study

Summary

The purpose of the study is to assess growth and tolerance in new born and infant fed an experimental infant formula with reduced total protein concentration, enriched in alpha-lactalbumin and containing a symbiotic.

Conditions

  • Growth

Interventions

DIETARY_SUPPLEMENT

Pétunia 1

Infant formula used for non breastfed children

DIETARY_SUPPLEMENT

Regular formula

Infant formula used for non breastfed children

Sponsors & Collaborators

  • Sodilac

    lead INDUSTRY

Principal Investigators

  • Jean Christophe Rozé, PhD · Nantes University Hospital

Study Design

Allocation
RANDOMIZED
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Max Age
8 Days
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-02-28
Primary Completion
2008-03-31
Completion
2008-03-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00920166 on ClinicalTrials.gov